What Happened?
Cambridge, MA-based Solid-Biosciences Appointed Ilan Ganot as Chief Executive Officer
About the Company
Solid Biosciences (Solid) is a life science company singularly focused on solving Duchenne muscular dystrophy (Duchenne). We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Cambridge, MA, USA.
About the Person
Mr. Ganot is Founder, CEO of Solid Biosciences and Solid GT and member of the board of directors of both companies. Prior to starting Solid, Mr. Ganot was an investment banker at JPMorgan Chase in London, specializing in hedge funds driven equities business for the firm. Mr. Ganot also worked at Nomura Securities in London, Hong Kong and New York and Lehman Brothers in Europe. Mr. Ganot embarked on a banking career after practicing law at Israeli law-firm, Haim Zadok & Co, where his focus was private equity law and mergers and acquisitions. Mr. Ganot was a captain in the Israel Defense Forces. Mr. Ganot received his MBA from London Business school and holds law and business degrees from the IDC in Herzliya, Israel.
Info Source
Press Release
Short Profile